免疫の世界市場2018-2022:自己免疫疾患、腫瘍学、臓器移植、その他

◆英語タイトル:Global Immunology Market 2018-2022
◆発行会社/調査会社:Technavio
◆商品コード:IRTNTR20037
◆発行日:2018年1月8日
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆ページ数:117
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[免疫の世界市場2018-2022:自己免疫疾患、腫瘍学、臓器移植、その他]についてメールでお問い合わせはこちら
Technavio社が発行した当調査レポートでは、免疫の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、免疫の世界市場規模及び予測、カテゴリー別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。
*** レポート概要(サマリー)***

About ImmunologyThe immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body’s healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body’s defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body’s cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.

Technavio’s analysts forecast the global immunology market to grow at a CAGR of 4.57% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global immunology market for 2018-2022. To calculate the market size, the report considers the revenue generated from the immunology.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Immunology Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AbbVie
• Amgen
• F. Hoffmann-La Roche
• Johnson & Johnson

[Other prominent vendors]
• Angimmune
• Bionor Pharma
• Boston Biomedical
• Celgene
• Cellectar Biosciences
• eFFECTOR Therapeutics
• Forty Seven
• HANSOH
• Immatics Biatechnologies
• lmmunovaccine
• Karyopharm Therapeutics
• MabVax Therapeutics
• MedImmune
• MOLOGEN
• Neon Therapeutics
• NewLink Genetics
• Novartis
• ONCOQUEST
• Oncotherapeutics.

[Market driver]
• Growing cases of infectious diseases
• For a full, detailed list, view our report

[Market trend]
• Significant pipeline
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

*** レポート目次(コンテンツ)***

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
• Market outline

PART 05: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 06: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast

PART 07: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 08: PIPELINE LANDSCAPE

PART 09: MARKET SEGMENTATION BY CATEGORY
• Segmentation by category
• Comparison by category
• Global immunosuppressants market
• Global immuno boosters market
• Market opportunity by category

PART 10: MARKET SEGMENTATION BY INDICATION
• Autoimmune diseases
• Oncology
• Organ transplantation
• Others

PART 11: CUSTOMER LANDSCAPE

PART 12: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Immunology market in Americas
• Immunology market in EMEA
• Immunology market in APAC
• Market opportunity

PART 13: DECISION FRAMEWORK

PART 14: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 15: MARKET TRENDS
• Significant pipeline
• Collaborations and partnerships for R&D
• Advanced diagnostic technologies

PART 16: VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 17: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie
• Amgen
• F. Hoffmann-La Roche
• Johnson & Johnson

PART 18: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Parent market
Exhibit 02: Global immunology market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition: Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global immunology market 2017-2022 ($ billions)
Exhibit 09: Global immunology market: Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Pipeline landscape by development phase
Exhibit 19: Key clinical trials
Exhibit 20: Global immunology market by category 2017-2022 (%)
Exhibit 21: Comparison by category
Exhibit 22: Immunosuppressant drugs
Exhibit 23: Global immunosuppressants market 2017-2022 ($ billions)
Exhibit 24: Global immunosuppressants market: Year-over-year growth 2018-2022 (%)
Exhibit 25: Classification of immuno boosters
Exhibit 26: Global immuno boosters market 2017-2022 ($ billions)
Exhibit 27: Global immuno boosters market: Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by category
Exhibit 29: Brief history of immuno-oncology
Exhibit 30: Stages of anti-tumor immune response
Exhibit 31: Customer landscape
Exhibit 32: Global immunology market by geography 2017-2022 (%)
Exhibit 33: Regional comparison
Exhibit 34: Immunology market in Americas 2017-2022 ($ billions)
Exhibit 35: Immunology market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 36: Top three countries in Americas
Exhibit 37: Immunology market in EMEA 2017-2022 ($ billions)
Exhibit 38: Immunology market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 39: Top three countries in EMEA
Exhibit 40: Immunology market in APAC 2017-2022 ($ billions)
Exhibit 41: Immunology market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 42: Top three countries in APAC
Exhibit 43: Market opportunity
Exhibit 44: Rise in organ transplantation in US 2015-2016
Exhibit 45: Organ transplantation by donor type 2016
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: AbbVie: Vendor overview
Exhibit 52: AbbVie: Business segments
Exhibit 53: AbbVie: Organizational developments
Exhibit 54: AbbVie: Geographic focus
Exhibit 55: AbbVie: Segment focus
Exhibit 56: AbbVie: Key offerings
Exhibit 57: Amgen: Vendor overview
Exhibit 58: Amgen: Business segments
Exhibit 59: Amgen: Organizational developments
Exhibit 60: Amgen: Geographic focus
Exhibit 61: Amgen: Segment focus
Exhibit 62: Amgen: Key offerings
Exhibit 63: F. Hoffmann-La Roche: Vendor overview
Exhibit 64: F. Hoffmann-La Roche: Business segments
Exhibit 65: F. Hoffman-La Roche: Organizational developments
Exhibit 66: F. Hoffmann-La Roche: Geographic focus
Exhibit 67: F. Hoffmann-La Roche: Segment focus
Exhibit 68: F. Hoffmann-La Roche: Key offerings
Exhibit 69: Johnson & Johnson: Vendor overview
Exhibit 70: Johnson & Johnson: Business segments
Exhibit 71: Johnson & Johnson: Organizational developments
Exhibit 72: Johnson & Johnson: Geographic focus
Exhibit 73: Johnson & Johnson: Segment focus
Exhibit 74: Johnson & Johnson: Key offerings



*** 掲載企業 ***

AbbVie, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Angimmune, Bionor Pharma, Boston Biomedical, Celgene, Cellectar Biosciences, eFFECTOR Therapeutics, Forty Seven, HANSOH, Immatics Biatechnologies, lmmunovaccine, Karyopharm Therapeutics, MabVax Therapeutics, MedImmune, MOLOGEN, Neon Therapeutics, NewLink Genetics, Novartis, ONCOQUEST, and Oncotherapeutics.


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR20037 )"免疫の世界市場2018-2022:自己免疫疾患、腫瘍学、臓器移植、その他" (英文:Global Immunology Market 2018-2022)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。